MDC.L लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 May 2023 @ 16:10):

Stats
आज की मात्रा	450.00
औसत मात्रा	3.85M
बाजार मूल्य	3.69B
EPS	£0 ( 2023-11-14 )
Last Dividend	£3.00 ( 2022-08-04 )
Next Dividend	£0 ( N/A )
P/E	21.78
ATR14	£1.585 (0.32%)

मात्रा सहसंबंध

लंबा: 0.13 (neutral)

छोटा: -0.04 (neutral)

Signal:(60.912) Neutral

Mediclinic International सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Mediclinic International सहसंबंध - मुद्रा/वस्त्र

0.08
( neutral )

0.22
( neutral )

-0.07
( neutral )

-0.09
( neutral )

0.23
( neutral )

-0.34
( neutral )

Mediclinic International वित्तीय

Annual	2022
राजस्व:	£3.23B
सकल लाभ:	£505.00M (15.62 %)
EPS:	£0.210

FY	2022
राजस्व:	£3.23B
सकल लाभ:	£505.00M (15.62 %)
EPS:	£0.210

FY	2021
राजस्व:	£3.00B
सकल लाभ:	£426.00M (14.22 %)
EPS:	£0.0920

FY	2020
राजस्व:	£3.08B
सकल लाभ:	£1.12B (36.43 %)
EPS:	£-0.434

Financial Reports:

No articles found.

Mediclinic International Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£3.00 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Mediclinic International Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.34 - good (83.45%) | Divividend Growth Potential Score: 4.50 - Potential for dividend initiation, but uncertain (10.07%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£5.24	2016-06-16
Last Dividend	£3.00	2022-08-04
Next Dividend	£0	N/A
Payout Date	2022-08-26
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	£35.14	--
Avg. Dividend % Per Year	0.19%	--
Score	2.59	--
Div. Sustainability Score	8.34
Div.Growth Potential Score	4.50
Div. Directional Score	6.42	--

Next Divdend (Est)
(2024-11-04)

£0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

2.59

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2016	£0	0.00%
2017	£0	0.00%
2018	£7.90	1.17%
2019	£7.90	2.50%
2020	£0	0.00%
2021	£0	0.00%
2022	£3.00	0.94%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
BPCR.L	Dividend Knight	2023-08-17	Quarterly	8	1.46%
OXIG.L	Dividend Knight	2023-08-03	Semi-Annually	32	0.64%
FCIT.L	Dividend King	2023-06-29	Quarterly	52	0.89%
SUPR.L	Dividend Knight	2023-07-13	Quarterly	8	3.25%
KEYS.L	Dividend Knight	2023-09-21	Annually	7	2.29%
CCJI.L	Dividend Knight	2023-07-06	Semi-Annually	9	2.14%
QXT.L	Ex Dividend Junior	2023-07-27	Sporadic	11	0.46%
GHH.L	Dividend Knight	2023-06-22	Annually	27	0.91%
AMC.L	Dividend Knight	2023-06-01	Insufficient data to determine frequency	2	55.57%
TPFG.L	Dividend Knight	2023-09-21	Annually	11	3.16%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0467	1.500	9.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0210	1.200	9.30	10.00	[0 - 0.3]
returnOnEquityTTM	0.0507	1.500	-0.548	-0.822	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.791	0.800	6.04	4.84	[1 - 3]
quickRatioTTM	0.656	0.800	-0.846	-0.677	[0.8 - 2.5]
cashRatioTTM	0.649	1.500	7.51	10.00	[0.2 - 2]
debtRatioTTM	0.359	-1.500	4.01	-6.02	[0 - 0.6]
interestCoverageTTM	4.52	1.000	9.44	9.44	[3 - 30]
operatingCashFlowPerShareTTM	0.751	2.00	9.75	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.509	2.00	9.75	10.00	[0 - 20]
debtEquityRatioTTM	0.833	-1.500	6.67	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.156	1.000	-0.730	-0.730	[0.2 - 0.8]
operatingProfitMarginTTM	0.0866	1.000	-0.268	-0.268	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.214	1.000	9.92	9.92	[0.2 - 2]
assetTurnoverTTM	0.449	0.800	-0.343	-0.274	[0.5 - 2]
Total Score				8.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	24.46	1.000	7.63	0	[1 - 100]
returnOnEquityTTM	0.0507	2.50	-0.352	-0.822	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.509	2.00	9.83	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.751	2.00	9.75	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	19.07	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.171	1.000	8.22	0	[0.1 - 0.5]
Total Score				4.50

Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.